Articles from Supernus, Inc.

ROCKVILLE, Md., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Supernus, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack A. Khattar, President and CEO of Supernus, Inc., will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference in London on Monday, November 16, 2026, at 8:30 a.m. EST (1:30 p.m. GMT).